
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Description
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Inflammatory Disease Markers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Inflammatory Disease Markers are antigen/antibodies that detect specific antigen/antibodies produced by bone, cartilage or any other inflammatory disease activity.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Inflammatory Disease Markers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inflammatory Disease Markers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Inflammatory Disease Markers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
180 Pages
- About GlobalData
- Inflammatory Disease Markers Overview
- Inflammatory Disease Markers - Pipeline Products by Stage of Development
- Inflammatory Disease Markers - Pipeline Products by Segment
- Inflammatory Disease Markers - Pipeline Products by Territory
- Inflammatory Disease Markers - Pipeline Products by Regulatory Path
- Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date
- Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
- Inflammatory Disease Markers – Companies Pipeline Products by Stage of Development
- Company Overview
- 1Drop Diagnostics Company Overview
- 4F Biotech Srl Company Overview
- Abcodia Ltd Company Overview
- Adaltis Srl Company Overview
- Age Labs AS Company Overview
- Albert Ludwigs University of Freiburg Company Overview
- AnaMar AB Company Overview
- AnteoTech Pty Ltd Company Overview
- Arizona State University Company Overview
- AXO Science SAS Company Overview
- Beckman Coulter Inc Company Overview
- BIOHOPE Scientific SL Company Overview
- Biomedal SL Company Overview
- BioMEMS Diagnostics Inc Company Overview
- BiomX Inc Company Overview
- BioSIMS Company Overview
- Boditech Med Inc Company Overview
- BRI Pharma Co Ltd Company Overview
- Castle Biosciences Inc Company Overview
- CD Diagnostics Inc Company Overview
- CDI Laboratories Inc Company Overview
- Cernostics Inc Company Overview
- Chronix Biomedical Inc Company Overview
- Cincinnati Children's Hospital Medical Center Company Overview
- Crescendo Bioscience Inc Company Overview
- Cyted Ltd Company Overview
- Detact Diagnostics BV Company Overview
- Diafir Company Overview
- DSX Therapeutics LLC Company Overview
- EKF Diagnostics Holdings Plc Company Overview
- ELITechGroup Inc Company Overview
- ET Healthcare Inc Company Overview
- Exagen Diagnostics Inc Company Overview
- Firalis SAS Company Overview
- French National Institute of Health and Medical Research Company Overview
- G Medical Health and Wellness Company Overview
- Genalyte Inc Company Overview
- Genetic Analysis AS Company Overview
- Genfit SA Company Overview
- Ghent University Company Overview
- GoodGut SL Company Overview
- Guangzhou Wondfo Biotech Co Ltd Company Overview
- Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview
- Ignyta Inc Company Overview
- InterVenn BioSciences Company Overview
- IPDx Immunoprofiling Diagnostics GmbH Company Overview
- IV Diagnostics Inc Company Overview
- Johns Hopkins University Company Overview
- KineMed Inc Company Overview
- LifeAssays AB Company Overview
- LightDeck Diagnostics Inc Company Overview
- Mabdx Inc Company Overview
- Medica Corp Company Overview
- Merck Millipore Corp Company Overview
- Metabolon Inc Company Overview
- Morehouse School of Medicine Company Overview
- MyHealthChecked Plc Company Overview
- MYND Diagnostics Ltd Company Overview
- Myriad Genetics Inc Company Overview
- Nagoya City University Company Overview
- Neoteryx LLC Company Overview
- Northwestern University Company Overview
- Ortho Clinical Diagnostics Holdings Plc Company Overview
- Oxford Biodynamics Plc Company Overview
- Paragraf Ltd Company Overview
- Phagolum Ltd. Company Overview
- Proplex Technologies Llc Company Overview
- Protagen AG Company Overview
- ProteinLogic Ltd Company Overview
- Queen Mary University of London Company Overview
- Roche Diagnostics Corp Company Overview
- Siemens Healthcare Diagnostics Inc Company Overview
- Singulex Inc Company Overview
- SomaLogic Inc Company Overview
- SpinChip Diagnostics AS Company Overview
- SQI Diagnostics Inc Company Overview
- StageZero Life Sciences Ltd Company Overview
- Svar Life Science AB Company Overview
- The University of Manchester Company Overview
- The Walter and Eliza Hall Institute of Medical Research Company Overview
- Thermo Fisher Scientific Inc Company Overview
- Toscana Biomarkers Srl Company Overview
- University Health Network Company Overview
- University of Aberdeen Company Overview
- University of Auckland Company Overview
- University of California Company Overview
- University of California Los Angeles Company Overview
- University of California San Francisco Company Overview
- University of Gottingen Company Overview
- University of Newcastle Company Overview
- University of Oxford Company Overview
- University of Rochester Company Overview
- University of Warwick Company Overview
- University Rovira i Virgili Company Overview
- Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference
- Aug 24, 2023: LumiraDx Reports Second Quarter 2023 Results
- Aug 17, 2023: Myriad Genetics to Host Investor Day on September 19, 2023
- Aug 16, 2023: LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
- Aug 14, 2023: Thermo Fisher Scientific to Trim Staff by More Than 200 at Florida Site
- Jul 17, 2023: Theradiag Reports Revenue of €6.7 Million for the First Half of 2023, up 6.8%
- Jul 05, 2023: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
- Jun 15, 2023: Arvinas Announces Changes to its Board of Directors
- Jun 05, 2023: StageZero Life Sciences Announces Special and Annual General Meeting Conference Call
- May 30, 2023: SQI Diagnostics reports second quarter 2023 results
- May 10, 2023: VolitionRx announces first quarter 2023 financial results and business update
- May 09, 2023: LumiraDx to announce first quarter financial results and host quarterly conference call on May 16
- May 05, 2023: VolitionRx schedules first quarter 2023 earnings conference call and business update
- May 03, 2023: Myriad Genetics reports first quarter 2023 financial results
- May 01, 2023: Brand new LifeLabs Patient Service Centre opens in Komoka, Ontario
- Mar 31, 2023: StageZero Life Sciences Announces Q4 2022 and Year End Financial Results and Operational Update
- Mar 30, 2023: StageZero to Issue Q4 2022 Financial Results on Friday March 31
- Mar 29, 2023: StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
- Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
- Mar 15, 2023: VolitionRx Announces Full Fiscal Year 2022 Financial Results and Business Update
- Mar 14, 2023: LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
- Mar 10, 2023: VolitionRx Schedules Full Year 2022 Earnings Conference Call and Business Update
- Mar 08, 2023: Otsuka Pharmaceutical Announces Appointments of Board Members and Statutory Auditors
- Mar 06, 2023: VolitionRx to Webcast Live at VirtualInvestorConferences.com March 9th
- Jan 16, 2023: TheraDiag Reports 2022 Revenue of €12.2 Million, up 9.7%
- Jan 09, 2023: NIH funds eight studies to advance rapid diagnosis of COVID-19-related inflammatory syndrome in children
- Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
- Jan 03, 2023: Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing its Expanded Clinical Portfolio
- Dec 19, 2022: Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
- Nov 21, 2022: Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
- Nov 15, 2022: StageZero Life Sciences Announces Q3 2022 Financial Results and Operational Update
- Nov 11, 2022: StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022
- Nov 09, 2022: VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update
- Nov 02, 2022: LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9
- Oct 31, 2022: Molecure Third Quarter 2022 Pipeline Highlights and Financial Results
- Oct 31, 2022: Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member
- Oct 27, 2022: Bio-Rad Reports Third-Quarter 2022 Financial Results
- Oct 17, 2022: Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
- Sep 30, 2022: Theradiag: Appointment of an Independent Expert
- Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.